SEARCH

SEARCH BY CITATION

REFERENCES

  • Ajima R, Ikematsu N, Ohsugi M, Yoshida Y, Yamamoto T. 2000. Cloning and characterization of the mouse tob2 gene. Gene 253: 215220.
  • Bellipanni G, Varga M, Maegawa S, Imai Y, Kelly C, Myers AP, Chu F, Talbot WS, Weinberg ES. 2006. Essential and opposing roles of zebrafish beta-catenins in the formation of dorsal axial structures and neurectoderm. Development 133: 12991309.
  • Bogdan JA, Adams-Burton C, Pedicord DL, Sukovich DA, Benfield PA, Corjay MH, Stoltenborg JK, Dicker IB. 1998. Human carbon catabolite repressor protein (CCR4)-associative factor 1: cloning, expression and characterization of its interaction with the B-cell translocation protein BTG1. Biochem J 336(Pt 2): 471481.
  • Bourbon HM, Gonzy-Treboul G, Peronnet F, Alin MF, Ardourel C, Benassayag C, Cribbs D, Deutsch J, Ferrer P, Haenlin M, Lepesant JA, Noselli S, Vincent A. 2002. A P-insertion screen identifying novel X-linked essential genes in Drosophila. Mech Dev 110: 7183.
  • Bradbury A, Possenti R, Shooter EM, Tirone F. 1991. Molecular cloning of PC3, a putatively secreted protein whose mRNA is induced by nerve growth factor and depolarization. Proc Natl Acad Sci U S A 88: 33533357.
  • Buanne P, Corrente G, Micheli L, Palena A, Lavia P, Spadafora C, Lakshmana MK, Rinaldi A, Banfi S, Quarto M, Bulfone A, Tirone F. 2000. Cloning of PC3B, a novel member of the PC3/BTG/TOB family of growth inhibitory genes, highly expressed in the olfactory epithelium. Genomics 68: 253263.
  • Caldwell RB, Kierzek AM, Arakawa H, Bezzubov Y, Zaim J, Fiedler P, Kutter S, Blagodatski A, Kostovska D, Koter M, Plachy J, Carninci P, Hayashizaki Y, Buerstedde JM. 2005. Full-length cDNAs from chicken bursal lymphocytes to facilitate gene function analysis. Genome Biol 6: R6.
  • Casellas R, Brivanlou AH. 1998. Xenopus Smad7 inhibits both the activin and BMP pathways and acts as a neural inducer. Dev Biol 198: 112.
  • Chen P, Ellis RE. 2000. TRA-1A regulates transcription of fog-3, which controls germ cell fate in C. elegans. Development 127: 31193129.
  • Chen PJ, Singal A, Kimble J, Ellis RE. 2000. A novel member of the tob family of proteins controls sexual fate in Caenorhabditis elegans germ cells. Dev Biol 217: 7790.
  • Chen PJ, Cho S, Jin SW, Ellis RE. 2001. Specification of germ cell fates by FOG-3 has been conserved during nematode evolution. Genetics 158: 15131525.
  • De Robertis EM, Kuroda H. 2004. Dorsal-ventral patterning and neural induction in Xenopus embryos. Annu Rev Cell Dev Biol 20: 285308.
  • Dragon S, Offenhauser N, Baumann R. 2002. cAMP and in vivo hypoxia induce tob, ifr1, and fos expression in erythroid cells of the chick embryo. Am J Physiol Regul Integr Comp Physiol 282: R1219R1226.
  • Ellis RE, Kimble J. 1995. The fog-3 gene and regulation of cell fate in the germ line of Caenorhabditis elegans. Genetics 139: 561577.
  • Fletcher BS, Lim RW, Varnum BC, Kujubu DA, Koski RA, Herschman HR. 1991. Structure and expression of TIS21, a primary response gene induced by growth factors and tumor promoters. J Biol Chem 266: 1451114518.
  • Grange T, de Sa CM, Oddos J, Pictet R. 1987. Human mRNA polyadenylate binding protein: evolutionary conservation of a nucleic acid binding motif. Nucleic Acids Res 15: 47714787.
  • Guehenneux F, Duret L, Callanan MB, Bouhas R, Hayette S, Berthet C, Samarut C, Rimokh R, Birot AM, Wang Q, Magaud JP, Rouault JP. 1997. Cloning of the mouse BTG3 gene and definition of a new gene family (the BTG family) involved in the negative control of the cell cycle. Leukemia 11: 370375.
  • Hata A, Lagna G, Massague J, Hemmati-Brivanlou A. 1998. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev 12: 186197.
  • Holland ND, Zhang SC, Clark M, Panopoulou G, Lehrach H, Holland LZ. 1997. Sequence and developmental expression of AmphiTob, an amphioxus homolog of vertebrate Tob in the PC3/BTG1/Tob family of tumor suppressor genes. Dev Dyn 210: 1118.
  • Ikematsu N, Yoshida Y, Kawamura-Tsuzuku J, Ohsugi M, Onda M, Hirai M, Fujimoto J, Yamamoto T. 1999. Tob2, a novel anti-proliferative Tob/BTG1 family member, associates with a component of the CCR4 transcriptional regulatory complex capable of binding cyclin-dependent kinases. Oncogene 18: 74327441.
  • Ito Y, Suzuki T, Yoshida H, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Yamamoto T, Miyauchi A. 2005. Phosphorylation and inactivation of Tob contributes to the progression of papillary carcinoma of the thyroid. Cancer Lett 220: 237242.
  • Iwanaga K, Sueoka N, Sato A, Sakuragi T, Sakao Y, Tominaga M, Suzuki T, Yoshida Y, J KT, Yamamoto T, Hayashi S, Nagasawa K, Sueoka E. 2003. Alteration of expression or phosphorylation status of tob, a novel tumor suppressor gene product, is an early event in lung cancer. Cancer Lett 202: 7179.
  • Jin M, Wang XM, Tu Y, Zhang XH, Gao X, Guo N, Xie Z, Zhao G, Jing N, Li BM, Yu L. 2005. The negative cell cycle regulator, Tob (transducer of ErbB-2), is a multifunctional protein involved in hippocampus-dependent learning and memory. Neuroscience 131: 647659.
  • Kahvejian A, Svitkin YV, Sukarieh R, M'Boutchou MN, Sonenberg N. 2005. Mammalian poly(A)-binding protein is a eukaryotic translation initiation factor, which acts via multiple mechanisms. Genes Dev 19: 104113.
  • Kawamura-Tsuzuku J, Suzuki T, Yoshida Y, Yamamoto T. 2004. Nuclear localization of Tob is important for regulation of its antiproliferative activity. Oncogene 23: 66306638.
  • Kawate H, Wu Y, Ohnaka K, Nawata H, Takayanagi R. 2005. Tob proteins suppress steroid hormone receptor-mediated transcriptional activation. Mol Cell Endocrinol 230: 7786.
  • Kimble JE, White JG. 1981. On the control of germ cell development in Caenorhabditis elegans. Dev Biol 81: 208219.
  • Liu HY, Badarinarayana V, Audino DC, Rappsilber J, Mann M, Denis CL. 1998. The NOT proteins are part of the CCR4 transcriptional complex and affect gene expression both positively and negatively. EMBO J 17: 10961106.
  • Maekawa M, Nishida E, Tanoue T. 2002. Identification of the Anti-proliferative protein Tob as a MAPK substrate. J Biol Chem 277: 3778337787.
  • Maekawa M, Yamamoto T, Nishida E. 2004. Regulation of subcellular localization of the antiproliferative protein Tob by its nuclear export signal and bipartite nuclear localization signal sequences. Exp Cell Res 295: 5965.
  • Manolagas SC, Kousteni S, Jilka RL. 2002. Sex steroids and bone. Recent Prog Horm Res 57: 385409.
  • Matsuda S, Kawamura-Tsuzuku J, Ohsugi M, Yoshida M, Emi M, Nakamura Y, Onda M, Yoshida Y, Nishiyama A, Yamamoto T. 1996. Tob, a novel protein that interacts with p185erbB2, is associated with anti-proliferative activity. Oncogene 12: 705713.
  • Matsuda S, Rouault J, Magaud J, Berthet C. 2001. In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS Lett 497: 6772.
  • Moon RT, Kohn AD, De Ferrari GV, Kaykas A. 2004. WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5: 691701.
  • Nakayama T, Gardner H, Berg LK, Christian JL. 1998. Smad6 functions as an intracellular antagonist of some TGF-beta family members during Xenopus embryogenesis. Genes Cells 3: 387394.
  • Okochi K, Suzuki T, Inoue J, Matsuda S, Yamamoto T. 2005. Interaction of anti-proliferative protein Tob with poly(A)-binding protein and inducible poly(A)-binding protein: implication of Tob in translational control. Genes Cells 10: 151163.
  • Park GT, Seo EY, Lee KM, Lee DY, Yang JM. 2006. Tob is a potential marker gene for the basal layer of the epidermis and is stably expressed in human primary keratinocytes. Br J Dermatol 154: 411418.
  • Pourquie O. 2001. Vertebrate somitogenesis. Annu Rev Cell Dev Biol 17: 311350.
  • Prevot D, Morel AP, Voeltzel T, Rostan MC, Rimokh R, Magaud JP, Corbo L. 2001. Relationships of the antiproliferative proteins BTG1 and BTG2 with CAF1, the human homolog of a component of the yeast CCR4 transcriptional complex: involvement in estrogen receptor alpha signaling pathway. J Biol Chem 276: 96409648.
  • Rouault JP, Rimokh R, Tessa C, Paranhos G, Ffrench M, Duret L, Garoccio M, Germain D, Samarut J, Magaud JP. 1992. BTG1, a member of a new family of antiproliferative genes. EMBO J 11: 16631670.
  • Rouault JP, Prevot D, Berthet C, Birot AM, Billaud M, Magaud JP, Corbo L. 1998. Interaction of BTG1 and p53-regulated BTG2 gene products with mCaf1, the murine homolog of a component of the yeast CCR4 transcriptional regulatory complex. J Biol Chem 273: 2256322569.
  • Sasajima H, Nakagawa K, Yokosawa H. 2002. Antiproliferative proteins of the BTG/Tob family are degraded by the ubiquitin-proteasome system. Eur J Biochem 269: 35963604.
  • Schneider S, Steinbeisser H, Warga RM, Hausen P. 1996. Beta-catenin translocation into nuclei demarcates the dorsalizing centers in frog and fish embryos. Mech Dev 57: 191198.
  • Seeman E. 2004. Estrogen, androgen, and the pathogenesis of bone fragility in women and men. Curr Osteoporos Rep 2: 9096.
  • Shi K, Zhang L, Meng A. 2004. Cloning and expression analysis of zebrafish tob1 gene. Dev Genes Evol 214: 309311.
  • Suzuki T, Matsuda S, Tsuzuku JK, Yoshida Y, Yamamoto T. 2001. A serine/threonine kinase p90rsk1 phosphorylates the anti-proliferative protein Tob. Genes Cells 6: 131138.
  • Suzuki T, K-Tsuzuku J, Ajima R, Nakamura T, Yoshida Y, Yamamoto T. 2002. Phosphorylation of three regulatory serines of Tob by Erk1 and Erk2 is required for Ras-mediated cell proliferation and transformation. Genes Dev 16: 13561370.
  • Tian T, Meng AM. 2006. Nodal signals pattern vertebrate embryos. Cell Mol Life Sci 63: 672685.
  • Tzachanis D, Freeman GJ, Hirano N, van Puijenbroek AA, Delfs MW, Berezovskaya A, Nadler LM, Boussiotis VA. 2001. Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells. Nat Immunol 2: 11741182.
  • Usui M, Yoshida Y, Yamashita T, Tsuji K, Isao I, Yamamoto T, Nifuji A, Noda M. 2002. Enhancing effect of Tob deficiency on bone formation is specific to bone morphogenetic protein-induced osteogenesis. J Bone Miner Res 17: 10261033.
  • Usui M, Yoshida Y, Tsuji K, Oikawa K, Miyazono K, Ishikawa I, Yamamoto T, Nifuji A, Noda M. 2004. Tob deficiency superenhances osteoblastic activity after ovariectomy to block estrogen deficiency-induced osteoporosis. Proc Natl Acad Sci U S A 101: 66536658.
  • Wang XM, Gao X, Zhang XH, Tu YY, Jin ML, Zhao GP, Yu L, Jing NH, Li BM. 2006. The negative cell cycle regulator, Tob (transducer of ErbB-2), is involved in motor skill learning. Biochem Biophys Res Commun 340: 10231027.
  • Xiong B, Rui Y, Zhang M, Shi K, Jia S, Tian T, Yin K, Huang H, Lin S, Zhao X, Chen Y, Chen YG, Lin SC, Meng A. 2006. Tob1 controls dorsal development of zebrafish embryos by antagonizing maternal beta-catenin transcriptional activity. Dev Cell 11: 225238.
  • Yang H, Duckett CS, Lindsten T. 1995. iPABP, an inducible poly(A)-binding protein detected in activated human T cells. Mol Cell Biol 15: 67706776.
  • Yoshida Y, Matsuda S, Yamamoto T. 1997. Cloning and characterization of the mouse tob gene. Gene 191: 109113.
  • Yoshida Y, Matsuda S, Ikematsu N, Kawamura-Tsuzuku J, Inazawa J, Umemori H, Yamamoto T. 1998. ANA, a novel member of Tob/BTG1 family, is expressed in the ventricular zone of the developing central nervous system. Oncogene 16: 26872693.
  • Yoshida Y, Nakamura T, Komoda M, Satoh H, Suzuki T, Tsuzuku JK, Miyasaka T, Yoshida EH, Umemori H, Kunisaki RK, Tani K, Ishii S, Mori S, Suganuma M, Noda T, Yamamoto T. 2003a. Mice lacking a transcriptional corepressor Tob are predisposed to cancer. Genes Dev 17: 12011206.
  • Yoshida Y, Tanaka S, Umemori H, Minowa O, Usui M, Ikematsu N, Hosoda E, Imamura T, Kuno J, Yamashita T, Miyazono K, Noda M, Noda T, Yamamoto T. 2000. Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Cell 103: 10851097.
  • Yoshida Y, von Bubnoff A, Ikematsu N, Blitz IL, Tsuzuku JK, Yoshida EH, Umemori H, Miyazono K, Yamamoto T, Cho KW. 2003b. Tob proteins enhance inhibitory Smad-receptor interactions to repress BMP signaling. Mech Dev 120: 629637.